Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at the 2nd FDD Conclave


News provided by

Ideal Cures Private Limited

05 Jul, 2018, 08:30 IST

Share this article

Share toX

Share this article

Share toX

Winners of FDD Leadership Awards 2018 From L-R top row: Nitin Deshmukh, Dr. Kaur Chand Jindal, Dr. Ashok Omray, Ravi Uday Bhaskar (Chief Guest), Dr. Milind Biyani, Mr Naga Prasad Vishnubhotia (Jury), Viveka Rowchoudhary (Editor-in-chief – Express Pharma), Dr. Hemadri Sen (Scientific Committee), Suresh Pareek (Managing Director – Ideal Cures), Dr. Girish Jain (Jury), Vinod Kumar Arora (Jury), Pramod Pimplikar (Jury), Dr. Rakesh Kumar Bhasin, Dr. Venkata Naidu, Munish Talwar From L-R bottom row: Elayaraja Natarajan, Amit Mukhariya, Kishore Deo, Krishnakant Gandhi, Chandrashekhar Kandi, Pankaj Mandpe, Bijay Kumar Padhi, Dr. Raveendra Pai, Dr. Pirthi Pal Singh, Indu Bhushan, Dr. Praveen (PRNewsfoto/Ideal Cures Private Limited)
Winners of FDD Leadership Awards 2018 From L-R top row: Nitin Deshmukh, Dr. Kaur Chand Jindal, Dr. Ashok Omray, Ravi Uday Bhaskar (Chief Guest), Dr. Milind Biyani, Mr Naga Prasad Vishnubhotia (Jury), Viveka Rowchoudhary (Editor-in-chief – Express Pharma), Dr. Hemadri Sen (Scientific Committee), Suresh Pareek (Managing Director – Ideal Cures), Dr. Girish Jain (Jury), Vinod Kumar Arora (Jury), Pramod Pimplikar (Jury), Dr. Rakesh Kumar Bhasin, Dr. Venkata Naidu, Munish Talwar From L-R bottom row: Elayaraja Natarajan, Amit Mukhariya, Kishore Deo, Krishnakant Gandhi, Chandrashekhar Kandi, Pankaj Mandpe, Bijay Kumar Padhi, Dr. Raveendra Pai, Dr. Pirthi Pal Singh, Indu Bhushan, Dr. Praveen (PRNewsfoto/Ideal Cures Private Limited)
Ideal Cures Logo (PRNewsfoto/Ideal Cures Private Limited)
Ideal Cures Logo (PRNewsfoto/Ideal Cures Private Limited)

MUMBAI, July 5, 2018 /PRNewswire/ --

In a joint initiative, Ideal Cures - India's foremost film-coating and pharmaceutical excipient company - along with Express Pharma, India's leading pharmaceutical and biotechnology publication, in their endeavor to recognize and appreciate FR&D scientists conceptualized, initiated and sponsored the 'Formulation and Drug Delivery Leadership Awards' at the Formulation and Drug Delivery (FDD) Conclave 2018. In its second year, FDD Leadership Awards held on 15 June 2018, Hyderabad, saw over 110 formulation scientists come together, to celebrate and recognize the efforts of their colleagues. It was by virtue of quality nominations received that the award ceremony was a grand success. A jury team set up in 2017, assessed and analyzed each application and chose the crème de la crème based on pre-decided criteria. Depending upon an individual's years of experience, applicants were classified into three categories - Rising Stars, Leaders and Stalwarts. The second edition brought promises of industry leaders working together to better policies and usher in ground-breaking innovations.

     (Logo: https://mma.prnewswire.com/media/714539/Ideal_Cures_Logo.jpg )

     (Photo: https://mma.prnewswire.com/media/714568/Winners_FDD_Leadership_Awards_2018.jpg )

The event also saw an impressive product launch by Ideal Cures wherein a live product demo was conducted for their Quick Disintegrating Coating - INSTACOAT QD. With a disintegration time of anywhere between 3-15 secs, their new product was well received and is targeted to soon begin commercialization. Their other product - INSTACOAT T2F, targets the nutraceutical and pharmaceutical market that is on the increased look out for a coating free of both Talc and Titanium Di-oxide. INSTACOAT T2F has features at par with coatings that contain these two ingredients. These coatings are specifically formulated to provide easy scale-up and transfer to different manufacturing facilities.

Speaking on the launch, Mr. Suresh Pareek - Managing Director, Ideal Cures, said, "The mission of Ideal Cures is simply to 'Add Value'. We strive to add value to our customer's products through our renowned focus, innovation and creative thinking. Both our new innovations are based on this simple motto."

FDD Conclave 2018, humored to be an 'alumini meet', gives the industry's influencers a chance to meet their peers of over 30 decades. Being the first platform that awards and felicitates formulation scientists, FDD Conclave is poised on a growth trajectory that's only heading upwards.

About Ideal Cures: 

Ideal Cures (IC) is amongst India's leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. IC provides tailor-made solutions and products for the pharmaceutical and allied industries, through a network of customers and partners across more than 40 countries around the world. It is the first film coating company to have all its cGMP compliant manufacturing plants EXCiPACT™ certified. IC's latest manufacturing facility in Sikkim will be certified in due course. An ISO 9001:2015 certified company with a US DMF for all its manufacturing facilities, IC is one of the most innovative film-coating companies.

Website - http://www.idealcures.com

For a comprehensive, time-saving tablet coating experience, Talk to Us!
Join us on LinkedIn for quick updates on our new product launches and upcoming events!  

Media Contact:
Saryu Pareek Gupta
[email protected]
+91-22-42688700
Vice President - Corporate Communications
Ideal Cures Pvt. Ltd.

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.